A 15-year Single Center Experience of Endovascular Treatment of Transplant Renal Artery Stenosis
NCT ID: NCT03477071
Last Updated: 2018-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1323 participants
OBSERVATIONAL
2010-01-01
2017-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification and Treatment of Renal Stenosis in Transplanted Kidneys
NCT06822205
Transplant Renal Artery Stenosis: Observation Versus Stenting
NCT05046496
Endovascular Preparation for Kidney Tranplantation
NCT06677437
Aortoiliac Stenosis in Kidney Transplantation
NCT06020534
Long-term Cardiovascular Risk Following Successful Renal Transplantation
NCT01728012
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This retrospective, monocentric study included patients with peri-anastomotic stenosis of the renal graft from 2000 to 2017. The stenosis is defined by a reduction of at least 50% of the arterial diameter during arteriography. Technical success was defined as residual stenosis less than 30% of the arterial diameter after the procedure.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Angioplasty for Transplant Renal Artery Stenosis (TRAS)
The angioplasty is an endovascular treatment for artery stenosis, which could be associated with stenting or not.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients who had a Transplant Renal Artery Stenosis
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut National de la Santé Et de la Recherche Médicale, France
OTHER_GOV
Centre Hospitalier Universitaire de Nice
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
URO-BASE03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.